were over 70. The age related incidence rose from 58 44 In the present report, undertaken as part of the Renal Association's study of the provision of services for chronic renal failure, we have estimated the incidence of advanced chronic renal failure using the principle that for renal failure to be diagnosed a blood test must be done. Some patients may die of renal failure without the diagnosis ever being considered; thus our estimate of the incidence of advanced chronic renal failure is a conservative one. We defined advanced chronic renal failure as occurring when a serum creatinine concentration >500 imol/l was first recorded and then remained above this level. Not all of these patients would need dialysis; the number needing dialysis was assessed by following up and analysing the cohort.
Methods
The study covered three health districts, each with a stable population and a negligible cross boundary flow of patients. Each district has only one biochemical pathology laboratory. The Devon referred most patients; Blackburn, Hyndburn, and Ribble Valley had no renal unit at the time of the survey and referred to Manchester or, latterly, Preston.
In each of these geographical areas the single pathology laboratory always measured serum creatinine concentration whenever electrolyte concentrations were requested. Over the two years starting 1 January 1986 all creatinine results were screened and any patient with a concentration >500 imol/l was identified. The notes were studied subsequently or in cases of blood tests initiated by the general practitioner he or she was contacted to obtain further information. The last follow up assessment was made on 1 March 1990 for those referred to a renal unit. For those not referred for a nephrologist's opinion; six were insulin dependent. In Exeter health district (from which nine of the 10 diabetic patients in Devon with renal failure originated) there are over 3000 patients with diabetes, of whom over 600 are insulin dependent. Four of the diabetic patients have received dialysis, one has moved away, one was aged over 80, three died from non-renal causes, and one (already discussed) was not offered dialysis. In Blackburn only five of the 10 patients were referred for a nephrologist's opinion (this referral rate has risen since the study was completed). The incidence of diabetic patients with a creatinine concentration >500 [imol/I is similar to that estimated in the joint report of the British Diabetic Association, the Renal Association, and the Royal College of Physicians,6 which highlighted an apparent shortfall between those with a creatinine concentration >500 [tmol/l and those receiving dialysis. Our figures suggest that in some areas this may be due in part to patients dying of nonrenal causes after the serum creatinine concentration has risen above 500 emol/l but before dialysis is needed, rather than to discrimination against diabetic patients.
Discussion
The results from Blackburn and Devon, two areas with different socioeconomic characteristics, were -remarkably similar (figure). Even though a greater number ofcases in Exeter were judged to be "terminal" (this may have been a matter of definition), the incidence ofnon-acute renal failure was almost identical in the two areas. This encourages us to believe that these results may be representative of the United i-;.-SKingdom as a whole. This work was initiated by a subcommittee of the Renal Association set up to study the provision of renal services in the United Kingdom. The study was supported by grants from the Medical Research Council. We thank Elizabeth Boylan in Exeter and Sheila Maskery in Blackburn, who painstakingly collected the initial data, and Dr Ian Lewin who helped to collect and analyse the data from North Devon. We also thank the physicians of the three health districts who agreed to their patients being assessed in this way and the pathology laboratories for their cooperation.
Introduction
In 1984 members of the Renal Association became concerned about the shortfall of treatment provided for patients reaching end stage renal failure. They were well aware that in the United Kingdom standards were falling far short of those in Europe and the United States for levels of treatment, especially for older patients and for those with concurrent medical problems, such as diabetes mellitus. It had also become clear that there was considerable inequality in the facilities available in different parts of the United Kingdom. The association therefore decided to set up a subcommittee to investigate the number of patients who were likely to benefit from treatment and to assess the level of service provision and any shortfall in facilities.
Data were available on the number of patients receiving treatment through the statistics collected by the European Dialysis and Transplant Association.
